Clark Capital Management Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-35,267	Closed	-$2.86M	–	477
2025 Q1	$2.86M	Buy	+35,267	New	+$3.15M	0.02%	242
2024 Q3	–	Sell	-46,488	Closed	-$4.31M	–	444
2024 Q2	$4.31M	Buy	+46,488	New	+$4.17M	0.03%	182
2023 Q3	–	Sell	-41,224	Closed	-$3.43M	–	379
2023 Q2	$3.43M	Buy	41,224 +269	+0.7%	+$22.5K	0.03%	191
2023 Q1	$3.12M	Sell	40,955 -24,797	-38%	-$2.06M	0.03%	188
2022 Q4	$5.46M	Buy	65,752 +1,181	+2%	+$95.6K	0.05%	170
2022 Q3	$5.12M	Sell	64,571 -5,444	-8%	-$459K	0.07%	166
2022 Q2	$5.2M	Buy	+70,015	New	+$5.26M	0.07%	162
2017 Q4	–	Sell	-14,509	Closed	-$1.26M	–	334
2017 Q3	$1.26M	Buy	+14,509	New	+$1.16M	0.04%	200